Platform Console Team Work with us

Developing the future of transplantation.

Our AI matches donor offers, predicts rejection, and monitors every graft, for kidney, lung, and liver transplant teams.

Combining donor matching, rejection risk, and AI into an engine for transplant decisions.

Our platform brings every donor offer, risk signal, and outcome into one place, across kidney, lung, and liver. Every decision is faster, clearer, and fully traceable, backed by AI trained on real transplant data.

Match

We rank every donor offer against every candidate on your list in seconds. Blood type, HLA, size, distance, and urgency are weighed together automatically, so your team sees the best-fit recipients first and never loses a viable organ to slow, manual sorting.

Predict

We model rejection and graft-survival risk for each donor-to-recipient pairing before you accept. Every prediction is grounded in transplant immunology and real outcomes, giving your team the foresight to choose the organ most likely to last, not just the next one in line.

Monitor

We surface the earliest signs of rejection, often before routine labs move. Kairos tracks each graft continuously after surgery, flagging subtle shifts in function and biomarkers so problems are caught while there is still time to act and protect the transplant.

Kairos Labs gives transplant teams one place to match every donor offer, predict rejection before they accept, and monitor every graft after surgery. Faster decisions, fewer lost organs, and more transplants that last.

The platform

One system for the entire transplant workflow.

Donor offer ranking Live placement console Placement timeline Organ digital twin Biomarker intelligence Document intelligence Model and evidence Integrations
CandidateMatchRiskCold timeStatus
K. Mensah94%Low06:12Recommended
R. Alvarez88%Medium09:40Review
D. Okoye71%High12:05Hold
S. Haddad66%Medium13:22Hold
J. Cole58%High15:03Hold
AO

Amara Okafor

Living-donor kidney · Day 84 · Tacrolimus 4mg BID
Low rejection risk
Kairos Agent read 14 new records for this patient and populated 6 fields below.
Live
Organ function
Function: Good
dd-cfDNA %
0.19 %
▼ 0.14 since draw
eGFR mL/min
58
stable, 3 visits
Adherence 30d
96 %
on target
Biomarker trend
dd-cfDNA trendThreshold 1.0%
Organ
Living-donor kidney
Perfusion
94 %
Function
58 eGFR
Rejection risk
Low
dd-cfDNA
0.19 %
TRANSPLANT LAB REPORT2026-07-12
Amara Okafor · MRN 40219 · Living-donor kidney
Renal function
Creatinine1.2 mg/dL
eGFR58 mL/min
BUN18 mg/dL
Immunology
Donor-derived cfDNA0.19 %
HLA mismatch2 / 6
Medication
Tacrolimus4 mg BID
Extracted by Kairos Agent
14 sources read · 98% confidence · linked to source
eGFR58 mL/min
dd-cfDNA0.19 %
HLA mismatch2 / 6
Creatinine1.2 mg/dL
Tacrolimus4 mg BID
6 fields populatedApply to record
The team

Founders.

Nikhil Bhimireddy

Nikhil Bhimireddy

Co-founder & COO
Divyash Nath

Divyash Nath

Co-founder & CEO
Backgrounds from